Brown, Lisle/Cummings’s Ocugen OCGN Stock Holding History

Brown, Lisle/Cummings’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,000	Closed	-$1.09K	–	562
2023 Q2	$1.09K	Hold	2,000	–	–	﹤0.01%	534
2023 Q1	$1.71K	Buy	+2,000	New	+$2.18K	﹤0.01%	500

Other funds holding OCGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Brown, Lisle/Cummings's OCGN Position: Q3 2023 in Review

Brown, Lisle/Cummings sold out of Ocugen (OCGN) in Q3 2023, closing a stake of 2,000 shares — an estimated $1.09K sold.

Brown, Lisle/Cummings first reported a position in OCGN in Q1 2023 and held it in 2 quarters. The position peaked at $1.71K in Q1 2023. 78 funds tracked by Wall St. Rank hold OCGN as of Q3 2023.

Brown, Lisle/Cummings reported no remaining Ocugen position as of Q3 2023 after selling out during the quarter.
Brown, Lisle/Cummings sold 2,000 Ocugen shares in Q3 2023, an estimated $1.09K.
Brown, Lisle/Cummings first reported a position in Ocugen in Q1 2023 and held it in 2 quarters.
Brown, Lisle/Cummings's Ocugen position peaked at $1.71K in Q1 2023.
78 funds tracked by Wall St. Rank held Ocugen as of Q3 2023.

Based on Brown, Lisle/Cummings's 13F filing for Q3 2023, filed 1 Jul 2024.